Abbott stock tumbles below key moving averages as sellers dominate momentum: weekly outlook

Traders Union
All News
Financial News
Abbott Laboratories falls 3.16% this week

Highlights

Abbott shares are experiencing strong bearish momentum, trading well below key moving averages and near the week's lows at $86.64.
Momentum indicators confirm persistent selling pressure with oversold conditions, while buyers remain largely inactive and no technical buy signals are present.
The expected price range for the next week is $80.30 to $92.80, with high downside risk and a low probability of reversal.

Sales gains in core units offset as diagnostics weakness weighs on sentiment

Abbott received both FDA approval and a CE mark for a new AI-enabled imaging device, expanding its vascular technologies portfolio. The company reported 9.5% sales growth in its vascular segment for the first quarter and a 9% increase in nutritional segment revenues driven by price adjustments. However, Abbott's diagnostics business declined by 18.2% in 2025 due to lost government tenders after spending priorities changed.

Intensified bearish momentum this week with oversold technical signals

Technical signals on the weekly timeframe remain deeply bearish, with Abbott trading near the bottom of its 7-day range and well below all major weekly moving averages. The MA-20 at $108.05 acts as the closest resistance, far above the current price, while the MA-50 and MA-200 confirm medium- and long-term selling pressure. Weekly momentum indicators point to extreme weakness: RSI is close to 19.5 and Stochastic RSI is fully oversold, with CCI deep in negative territory. The MACD remains strongly negative, backed by a high ADX indicating persistent downside strength. Bull/Bear Power and the Awesome Oscillator both signal that sellers remain firmly in control, while weekly volatility is elevated at 7.35%.

Neutral consolidation favored next week amid persistent downside risks

Looking ahead over the next five trading days, the most likely scenario is for Abbott to consolidate near current levels, as selling may pause but buyers remain hesitant. The expected price range for the week is $80.30 to $92.80, with a less than 20% probability of meaningful upward movement due to the lack of any weekly Buy signals. A bullish breakout requires a close above $92.80, but current momentum suggests this is unlikely. If the price slips below $80.30, further downside could accelerate as no strong technical support is visible on the weekly chart.

Viktoras Karapetjanc, expert at Traders Union, highlights that Abbott Laboratories demonstrated notable resilience this week despite intense selling pressure and weak momentum readings. He sees opportunity in the company’s underlying fundamentals, with FDA and CE approvals for new AI-enabled imaging technology and solid growth in both vascular and nutritional segments supporting a positive outlook. Although the stock remains oversold and well below key moving averages, Karapetjanc believes that consolidation and stabilization are likely as investors process recent positive catalysts. In his view, any consolidation around current price levels represents a potential entry window if broader sentiment turns. "While sellers remain in control this week, I see structural strengths emerging from Abbott’s innovation pipeline and expect the market to offer attractive setups as confidence recovers."

Earlier, analysts noted that Abbott Laboratories was experiencing persistent downside pressure and a strongly bearish outlook across major technical indicators. The current weekly chart reinforces the bearish momentum and, given the lack of confirmed buy signals, traders should monitor for potential downside acceleration if the stock closes below $80.30 in the near term.

Source of Data: ABT Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.